"We're verbally screening visitors at our hospitals & cancer center. Don't visit if you have: Fever 100.4F+ Cough OR shortness of breath Recent case of pneumonia OR flu within 14 days Traveled internationally OR by cruise ship Had contact with a confirmed or investigatory case."

During the past decade, Orlando Heart Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 8 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Orlando Heart Center" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "Biotronik, Inc." with 2 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "United Therapeutics" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orlando Heart Center" #1 collaborator was "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Milton S. Hershey Medical Center" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Orlando Heart Center" are "Heart Failure" (6 trials), "Coronary Artery Disease" (4 trials), "Pulmonary Arterial Hypertension" (4 trials), "Atrial Fibrillation" (3 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Orlando Heart Center" in a lesser frequency.

Most popular intervention types in "Orlando Heart Center" are "Drug" (13 trials), "Device" (9 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "ATI-5923" (1 trials), "Ambrisentan" (1 trials), "Anticoagulation Therapy" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Orlando Heart Center" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Orlando Heart Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Orlando Heart Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Orlando Heart Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".